Home › Post-COVID Conditions (Long COVID) › NCT06883513
Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
Osteopathic Manipulative Therapy(OMT) Effects on Post-Acute Sequalae of COVID-19(PASC)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * \- Individuals must claim they have had a prior positive SARS-CoV-2 test at least 6-weeks before the consenting process to proceed with the study * Individuals must claim they have at least one of the following symptoms greater than 6-weeks post infection that is affecting their daily life(these symptoms correlate with the SBQ™-LC): Symptoms of Long Covid Inclusion Criteria: * Shortness of breath or Difficulty Breathing * Difficulty with Movement (balance or tremor) * Muscle Pain or stiffness * Changes in sexual desire * Worsening Generalized Pain * Difficulty with Sleep * Changes in Mood (anxiety or depression) * Changes in Erectile function (Biological males only) * Palpations (irregular heart beats) * Altered Taste * Changes in your Hair * Changes in urination * Dizziness * Altered Smell * Changes in Skin * Changes in bowels * Fatigue * Indigestion * Dry or irritated eyes * Changes in sweating * Difficulty with Cognition (memory or thinking) * Stomach Pain * Changes in menstruation (Biological females only) * Chills or shivering Exclusion Criteria: * If anyone denies they have any of the above symptoms before consent, they will be excluded from the trial * They will also be excluded from the trial if they have suffered any fractured bones in the last 3 months (this will further decrease risk to the patient as the patient will be moved by the physician during the treatment protocol) * Participants who are enrolled in other Long-COVID trials that have an intervention during their participation in this trial will be excluded. However, if they have a history of enrollment in a long-covid trial that has no interventions during this trial, they will not be excluded based on their history of acquiring experimental treatment.
About the study
This study is investigating the effects of using an Osteopathic Manipulative Therapy (OMT) treatment protocol that was shown to statistically improve smell in individuals suffering from Long-COVID olfactory (smell) dysfunction in a small single-blinded pilot trial conducted during 2021.
The questions this study is trying to answer are:
1. Does this OMT protocol improve other non-smell related Long-COVID symptoms 2. Do 2 OMT treatments improve Long-COVID symptoms more than 1 OMT treatment
Participants will:
1. Week 1: Take an digital survey regarding their Long-COVID symptoms undergo Long-COVID OMT treatment or a placebo treatment 2. Week 2: Take an digital survey regarding their Long-COVID symptoms then all will undergo Long-COVID OMT treatment 3. Week 3: Take an digital survey regarding their Long-COVID symptoms 4. Week 8: Take an digital survey regarding their Long-COVID symptoms
What is being tested
- Osteopathic Manipulative Therapy Long-COVID protocol (other)
- Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol (other)
Sponsor: University of Louisville · Participants: 20 · Started: May 1, 2025
Contact the study team
- Michael E Stenta, DO, Doctor of Osteopathic Medicine · Phone: 15137289344
- Rebecca Lynn, DO, Doctor of Osteopathic Medicine · Phone: 1-931-409-6699
Official record on ClinicalTrials.gov — NCT06883513
Locations in the U.S.
| Kentucky | University of Louisville Outpatient Care Center, Louisville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.